Cary, NC, United States of America

Rangan Maitra

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • Cary, NC (US) (2015 - 2023)
  • Research Triangle Park, NC (US) (2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Journey of Rangan Maitra

Introduction

Rangan Maitra, an accomplished inventor based in Cary, NC, has made significant contributions to the field of biochemistry through his innovative work on apelin receptor agonists. With a remarkable portfolio comprising 11 patents, Maitra's inventions are paving the way for advancements in therapeutic applications.

Latest Patents

Among his latest inventions, Rangan Maitra has developed two noteworthy patents. The first, titled "Heterocyclic Apelin Receptor (APJ) Agonists and Uses Thereof," focuses on agonists of the apelin receptor (APJ) with heterocyclic cores and outlines their potential applications. The second patent, "Apelin Receptor (APJ) Agonists and Uses Thereof," is similarly directed to agonists of the apelin receptor, demonstrating the versatility and significance of his research in this domain.

Career Highlights

Maitra currently works at the prestigious Research Triangle Institute, where he leverages his expertise to foster innovation and research in the biotechnological landscape. His work has not only expanded the boundaries of knowledge but has also contributed to developing practical solutions for medical challenges.

Collaborations

Throughout his career, Rangan has collaborated with notable colleagues such as Scott P. Runyon and Sanju Narayanan. These partnerships have enhanced the scope and impact of his research, fostering a collaborative environment that is conducive to groundbreaking discoveries.

Conclusion

Rangan Maitra's journey as an inventor exemplifies the spirit of innovation. His patents underscore the critical role he plays in advancing the field of biochemistry, particularly in relation to apelin receptor agonists. With continued collaboration and dedication, Maitra is poised to make further significant contributions to science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…